Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments
Byrne, Sarah E. ; Rothschild, Anthony J.
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Aged
Antidepressive Agents
Antidepressive Agents, Tricyclic
Clinical Trials as Topic
Depressive Disorder
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Drug Tolerance
Female
Humans
MEDLINE
Male
Middle Aged
Monoamine Oxidase Inhibitors
Placebo Effect
Recurrence
Research Design
Serotonin Uptake Inhibitors
Severity of Illness Index
United States
Psychiatry
Subject Area
Embargo Expiration Date
Abstract
BACKGROUND: Many patients with unipolar depression experience a return of depressive symptoms while taking a constant maintenance dose of an antidepressant.
METHOD: All cited studies were found using computerized literature searches of the MEDLINE database since 1966.
RESULTS: The return of depressive symptoms during maintenance antidepressant treatment has occurred in 9% to 57% of patients in published trials. Possible explanations include loss of placebo effect, pharmacologic tolerance, increase in disease severity, change in disease pathogenesis, the accumulation of a detrimental metabolite, unrecognized rapid cycling, and prophylactic inefficacy.
CONCLUSION: Although several strategies have been proposed to overcome the loss of antidepressant efficacy, double-blind controlled studies are needed to ascertain the optimal strategy for this perplexing clinical problem.
Source
J Clin Psychiatry. 1998 Jun;59(6):279-88.